Use of Cardiac Resynchronization Therapy Defibrillator in US Hospitals
Amneet Sandhu1,2, Haikun Bao3, Karl E Minges3
1Division of Cardiology, University of Colorado School of Medicine, Aurora.
Insights
Cardiac resynchronization therapy (CRT) use increased, with more guideline-concordant CRT defibrillator (CRT-D) implants. However, conduction abnormalities were linked to discordant implants, suggesting a need for better guideline understanding.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Device Therapy
Background:
- Cardiac resynchronization therapy (CRT) significantly reduces morbidity and mortality in selected heart failure patients with systolic dysfunction and dyssynchrony.
- Contemporary use patterns of CRT, particularly CRT defibrillators (CRT-D), following major guideline updates remain under-characterized.
Purpose of the Study:
- To evaluate the trends in CRT-D implantation rates in the United States.
- To assess the concordance of these implantations with the 2012 ACC/AHA/HRS guidelines.
- To identify factors associated with guideline-discordant CRT-D use.
Main Methods:
- A population-based study analyzing data from the National Cardiovascular Data Registry for implantable cardioverter-defibrillators.
- Inclusion of all new CRT-D implantations from January 1, 2012, to December 31, 2015, across 1710 hospitals.
- Determination of implantation rates concordant and discordant with 2012 guidelines.
Main Results:
- Among 88,923 patients, 83.1% received guideline-concordant CRT-D implants.
- The proportion of guideline-concordant implants rose from 81.2% in 2012 to 84.2% in 2015 (P < .001).
- Guideline-discordant implants were disproportionately clustered in a minority of hospitals and associated with conduction abnormalities like right bundle branch block and nonspecific intraventricular conduction delay.
Conclusions:
- Guideline-concordant CRT-D implantation rates increased post-guideline revision.
- A significant portion of guideline-discordant implants occurred at specific centers, highlighting potential areas for targeted education.
- Conduction abnormalities were more prevalent in discordant cases, indicating a need for improved understanding and application of current CRT guidelines.
Importance:
Cardiac resynchronization therapy (CRT) provides significant reduction in morbidity and mortality in select patients with left ventricular systolic dysfunction and specific parameters of electrocardiographic evidence of dyssynchrony. Relative to the 2012 American College of Cardiology/American Heart Association/Heart Rhythm Society guideline update for patient selection, little is known about the contemporary use of CRT in the United States.
Objective:
To describe the use of CRT defibrillator (CRT-D) in the period around guideline revision.
Design, Setting, And Participants:
All patients undergoing new CRT-D implantations in the National Cardiovascular Data Registry for implantable cardioverter-defibrillators from January 1, 2012, to December 31, 2015, at 1710 participating hospitals were identified for this population-based study. Rates of CRT-D implantation that were concordant and discordant with the 2012 American College of Cardiology/American Heart Association/Heart Rhythm Society update of the 2008 guidelines for device-based therapy were determined. Analysis began in January 2012.
Main Outcomes And Measures:
Increase in guideline-concordant CRT-D implantation.
Results:
Among 135 253 patients undergoing initial CRT-D implantation, 88 923 were included in the study cohort, of which 73 859 implants (83.1%) were guideline concordant. The proportion of guideline-concordant devices increased from 81.2% (16 710 of 20 481) in 2012 to 84.2% (20 515 of 24 356) in 2015 (P for trend < .001). Significant clustering was noted with 33% (565 of 1710) of hospitals accounting for greater than 70% (10 545 of 15 065) of guideline-discordant CRT-D implants. Conduction abnormalities, in particular, underlying right bundle branch block (3597 [23.9%] vs 7425 [10.1%]; P < .001) and nonspecific intraventricular conduction delay (3341 [22.2%] vs 4769 [6.5%]; P < .001) were more common in those who received guideline-discordant devices.
Conclusions And Relevance:
Rates of guideline-concordant CRT-D implantation increased during the study. The major fraction of guideline-discordant implants were clustered at a minority of hospitals. Conduction abnormalities, particularly non-left bundle branch block and nonspecific intraventricular conduction delay, correlated with guideline-discordant implants indicating continued opportunity for dissemination and understanding of guideline updates.
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
Gene Therapy
Group Therapy
Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...
Psychodynamic Therapy


